Jun Liu
Director/Board Member at CHANGZHOU QIANHONG BIOPHARMA CO.,LTD
Net worth: 18 M $ as of 30/04/2024
Profile
Jun Liu is currently a Director at Changzhou Qianhong Biopharma Co., Ltd., Zonhon Biopharma Institute, Inc., and Aucentra Therapeutics Pty Ltd.
He previously worked as a Director-Supervisory Board at Changzhou Bio-pharma Qianhong Co. Ltd.
and as a Member at Jiangsu Biological Technology Association.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
30/09/2022 | 18,044,733 ( 5.04% ) | 13 M $ | 30/04/2024 | |
30/09/2022 | 6,014,911 ( 0.65% ) | 4 M $ | 30/04/2024 |
Jun Liu active positions
Companies | Position | Start |
---|---|---|
CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Director/Board Member | 15/05/2015 |
Zonhon Biopharma Institute, Inc. | Director/Board Member | 09/02/2015 |
Aucentra Therapeutics Pty Ltd.
Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Aucentra Therapeutics Pty Ltd. is an Australian biotech company that develops advanced anti-cancer drugs. The private company is based in Adelaide, Australia. Established in 2017, the company focuses on breakthrough classes of drugs to address unmet medical needs for some of the most severe cancers, including leukaemia, breast cancer, colorectal cancer, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. The company's pipeline consists of first-in-class or novel kinase inhibitors in pre-clinical and clinical stage development, with a particular focus on targeting cyclin dependent kinases (cdks), known for their over-expression in cancer cells. The company was founded in 2017 by Shudong Wang, and the CEO is Joe Bayer. | Director/Board Member | - |
Former positions of Jun Liu
Companies | Position | End |
---|---|---|
Changzhou Bio-pharma Qianhong Co. Ltd. | Director/Board Member | - |
Jiangsu Biological Technology Association | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Health Technology |
Private companies | 4 |
---|---|
Jiangsu Biological Technology Association | |
Changzhou Bio-pharma Qianhong Co. Ltd. | |
Zonhon Biopharma Institute, Inc. | |
Aucentra Therapeutics Pty Ltd.
Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Aucentra Therapeutics Pty Ltd. is an Australian biotech company that develops advanced anti-cancer drugs. The private company is based in Adelaide, Australia. Established in 2017, the company focuses on breakthrough classes of drugs to address unmet medical needs for some of the most severe cancers, including leukaemia, breast cancer, colorectal cancer, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. The company's pipeline consists of first-in-class or novel kinase inhibitors in pre-clinical and clinical stage development, with a particular focus on targeting cyclin dependent kinases (cdks), known for their over-expression in cancer cells. The company was founded in 2017 by Shudong Wang, and the CEO is Joe Bayer. | Health Technology |
- Stock Market
- Insiders
- Jun Liu